MERIT Acquires OSOD to Expand Ophthalmic Preclinical Capabilities
January 22, 2025
MERIT, a global clinical trial endpoint and technology services provider, has acquired OSOD, LLC, a Madison-based ophthalmic preclinical services consortium with over 30 years of experience. The acquisition strengthens MERIT's ability to provide a seamless transition from preclinical to clinical phases of ocular drug and device development while retaining OSOD's management team and expert network.
- Buyers
- MERIT
- Targets
- OSOD, LLC
- Industry
- Healthcare Services
- Location
- Wisconsin, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Oragenics Acquires Odyssey Health Neurological Drug Assets
January 2, 2024
Pharmaceuticals
Oragenics, Inc. completed the acquisition of Odyssey Health, Inc.'s neurological drug therapy assets, including ONP-002, ONP-001 rights, a proprietary intranasal delivery device and related formulations. Odyssey retained its remaining assets and operations; Michael Redmond (former Odyssey CEO) was named President of Oragenics to oversee integration and advancement of the neurology pipeline as Oragenics prepares for Phase 2 studies of ONP-002.
-
Emmes Acquires Clinical Edge
September 28, 2022
Healthcare Services
Emmes, a global full-service clinical research organization, has acquired Clinical Edge, a Milwaukee-based provider of visual function examiner training and certification for ophthalmic clinical trials. The deal combines Clinical Edge with Emmes' Optym ophthalmology unit (rebranded OptymEdge), expanding Emmes' ophthalmology certification capabilities and geographic reach across the U.S., Europe and Asia.
-
Sitero Acquires studyOS
November 5, 2025
Healthcare Services
Sitero has acquired the AI assets and business of studyOS, integrating studyOS’s Ash AI Clinical Trial Agent into its Mentor eClinical suite and launching SiteroAI to create an AI-powered CRO. studyOS’s technical and AI engineering teams will join Sitero and Ellis Butterfield, former CEO of studyOS, is appointed CTO to lead integration and product strategy. The combined platform aims to deliver measurable 20–30% efficiency gains across the clinical development lifecycle beginning in 2026.
-
Advancing Sight Network and Miracles In Sight Merge to Form Precision Ocular Network
January 27, 2026
Healthcare Services
Advancing Sight Network (ASN) and Miracles In Sight (MIS), two eye-tissue nonprofits, announced a merger that will combine them into a single organization. The merged entity will operate as Precision Ocular Network starting January 1, 2026, bringing together eye banking, research, clinical trials, and cellular therapeutics.
-
Velocity Clinical Research Acquires Meridian Clinical Research
December 15, 2022
Healthcare Services
Velocity Clinical Research, a GHO-backed integrated research site organization, has acquired Meridian Clinical Research for an undisclosed amount. The deal creates the largest dedicated clinical research site organization globally (about 80 sites), expands Velocity's U.S. footprint to 25 states and adds Meridian's network of 35+ sites and experienced investigators and staff.
-
Olympus to Acquire Odin Vision
December 20, 2022
Medical Devices
Olympus Corporation has signed a definitive agreement to acquire London-based Odin Vision, a cloud-AI endoscopy company, for up to GBP 66 million in upfront and milestone payments. The purchase is part of Olympus' broader digital strategy to integrate AI-driven detection, diagnostics, and cloud-enabled workflow solutions into its Digital Endosuite to improve clinical decision-making and patient outcomes.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.